Apellis Pharmaceuticals, Inc. (APLS)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

29

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-Sep-24 4:20 PM View:	23-Sep-24 Option Exercise $60.67K	Dunlop A. Sinclair Director		Apellis Pharmaceuticals, Inc. - APLS	(11%) 284.53K to 252.13K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:15 PM View:	27-Sep-24 Gift 0	Watson David O. General Counsel		Apellis Pharmaceuticals, Inc. - APLS	0% 197.86K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 4:08 PM View:	16-Sep-24 Sale ($6.95K)	Chopas James George VP/Chief Accounting Officer		Apellis Pharmaceuticals, Inc. - APLS	(1%) 38.33K to 38.14K	0	0	--	--	Show Txns Hide Txns